SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs strong Q3 results and plans to rapidly expand AI-compute capacity are driving bullish interest, amplified by analyst upgrades and discussion of a potential Tesla merger. Traders remain divided, with some emphasizing growth and AI demand while others cite heavy capital spending, valuation concerns and a large share unlock as risks to the rally.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strives expanded Bitcoin treasury, supported by proceeds from its SATS preferred-stock offering, is driving bullish attention as traders point to continued BTC accumulation and momentum in the shares. Others warn that the preferred financing adds dividend obligations and claims ahead of common shareholders, tempering the bullish view.

Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 is headquartered in New York, NY.

Skydance Corp. - Ordinary Shares - Class B

Shares are drawing attention on speculation that SpaceX could invest in or partner with Skydance, after John Malone floated a potential multibillion-dollar deal. Traders are reacting bullishly to the prospect of new financing and distribution opportunities, though the deal remains unconfirmed and bears continue to point to Skydances heavy debt and warrant-related volatility.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is drawing attention ahead of its quarterly earnings report, with traders focused on guidance and what it may signal about AI-related and memory-chip equipment demand. The stocks pre-earnings slide has prompted debate between buyers expecting strong results and traders wary of high expectations, volatility, and further downside.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas pre-earnings move is drawing attention alongside the newly formed committees exploring a possible SpaceX merger, a prospect reinforced by SpaceXs strong results. Traders debate the potential upside against an uncertain deal and possible dilution, while others expect Teslas earnings and margin outlook to drive a volatile reaction.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

TD Cowens downgrade to Hold and softer sales outlook ahead of earnings are weighing on CMG, with traders focused on weak October sales and the risk of continued pressure on traffic. The selloff toward yearly lows has prompted dip-buying alongside bearish concerns about the companys outlook and food quality.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas quarterly results and outlook are driving attention, especially AI capital spending, Muse adoption, and whether those investments can translate into returns. Traders are split between expecting strong results and an AI-driven lift, and worrying that rising costs, margin pressure, and the New Mexico privacy penalty could weigh on the stock.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is centered on traders positioning around the full Phase 3 INTerpath-001 melanoma vaccine data with Merck at ESMO, following previously reported positive topline results. Bulls see the readout as validation of the cancer-vaccine opportunity, while bears warn that expectations and valuation are stretched and debate whether the event could trigger a sell-the-news pullback.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Uniteds quarterly results and lower-than-expected fourth-quarter profit outlook, pressured by elevated jet-fuel costs, are driving discussion. Despite the margin concerns, shares rebounded as traders focused on strong revenue and travel demand; others question the rally given weaker guidance and fuel-cost risks.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor is drawing attention ahead of the FDAs November 22 decision on deramiocel for Duchenne muscular dystrophy, with the current application focused on upper-limb function. Traders are split: supporters point to the Phase 3 endpoint and extension data, while skeptics cite the prior rejection, advisory committee vote, and disputed statistical analyses; the stocks weakness has also prompted unverified short-selling and manipulation claims.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cathie Wood-Led Ark Invest's Biggest Q3 Winners And Losers — PLTR, NVDA, TXG Led While TSLA, RKLB Dragged

Equity

Ark's latest quarterly report shows that several stocks made meaningful contributions across multiple ETFs.

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms

The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.

Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares

Across the ARK Genomic Revolution ETF and the ARK Innovation ETF, Wood bought $6.1 million in Recursion Pharmaceuticals, $1.2 million in Intellia Therapeutics, and $5.3 million in Veracyte.


Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year 

Twist’s Lilly agreement and involvement in Anthropic research highlight its role in building and testing AI-designed proteins.

Beyond Meta, Cathie Wood’s ARKG Loads Up On These 4 Biotech Names

ARK’s latest portfolio moves spotlighted IONS, VCYT, SCTX, and BEAM as the firm increased its biotech exposure alongside a major Meta purchase.


CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing  

Compass has said a rolling FDA application is already underway for its COMP360, with the package due to be completed in the fourth quarter of 2026 and a possible U.S. launch in the first half of 2027. 


What Is Cathie Wood Buying Now? Nvidia, SpaceX And Crypto Stocks Led ARK’s August Trades – While Cutting These Growth Stocks

Nvidia was ARK’s biggest August purchase, with roughly 548,000 shares added during the month.


SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future 

ARK sees a path toward custom cancer treatments for every patient, though current costs of $200,000-$300,000 remain a major hurdle.

CMPS Stock Clocks 25% Gains In August Ahead Of Application Filing For Drug, FDA Hearing On Psychedelics

The most closely watched next step for Compass is the completion of its application to the U.S. Food and Drug Administration for COMP360, its synthetic psilocybin treatment aimed at people with depression that has not responded to other options.

Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough

The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.

ARK ETF Trust - ARK Genomic Revolution ETF

Neutral Sentiment

<ul class="summary-bullets"><li>10x Genomics and Palantir were among the standout winners across Ark's portfolios.</li><li>Ark attributed the 10x Genomics rally to growing interest in single-cell sequencing and spatial analysis as sources of data for AI drug-discovery models.</li><li>Nvidia also made the cut, particularly across Ark's technology-focused portfolios.</li></ul>Cathie Wood-led Ark Invest's portfolios saw some dramatic winners and losers in the third quarter (Q3), with artificial intelligence, biotech, crypto and other disruptive-technology bets among the biggest drivers.Ark's latest quarterly report shows that several stocks made meaningful contributions across multiple ETFs, while Tesla Inc. (TSLA) and Rocket Lab Corp. (RKLB) emerged among the most notable drags. Ark's attribution figures measure each holding's contribution to its ETF's performance, rather than the stock's standalone return.<h2 class="st-heading-2">Ark’s Biggest Winners In Q3</h2>10x Genomics Inc. (TXG) was the standout winner across Ark's portfolios. The stock contributed 9.03 percentage points to ARK Genomic Revolution ETF’s (ARKG) 28.92% Q3 gain and 2.92 points to ARK Innovation ETF’s (ARKK) 10.39% return during the quarter.Ark attributed the rally to growing interest in single-cell sequencing and spatial analysis as sources of data for AI drug-discovery models. The firm also highlighted the launch of 10x's Atera spatial system, with orders already in place for the 40 shipments anticipated in 2026.Twist Bioscience Corp. (TWST) was another major biotech winner, contributing 6.51 points to ARKG and 2.55 points to ARKK. The stock jumped 87.83% during the quarter. Ark said Twist was increasingly recognized as a beneficiary of AI-driven drug discovery, including through its protein-characterization work for Anthropic.&nbsp;Tempus AI Inc. (TEM) also stood out, contributing 3.21 points to ARKG and 2.08 points to ARKK, while gaining 41.38% during the quarter.&nbsp;Then there was Palantir Technologies Inc. (PLTR), emerging as one of the most important cross-ETF winners. Palantir contributed 1.86 points to ARK Autonomous Technology &amp; Robotics ETF (ARKQ), 1.62 points to ARKK, 1.48 points to ARK Next Generation Technology ETF (ARKW), 2.39 points to ARK Blockchain &amp; Fintech Innovation ETF (ARKF) and 1.47 points to ARK Space &amp; Defense Innovation ETF (ARKX).Nvidia Corp. (NVDA) also made the cut, particularly across Ark's technology-focused portfolios. It contributed 0.49 points to ARKQ and 0.48 points to ARKX.<h2 class="st-heading-2">Biggest Losers</h2>Tesla was the clearest recurring drag across Ark's portfolios. It was the biggest detractor in ARKQ (-1.72 percentage points), ARKK (-1.75 points) and ARKW (-1.43 points).Ark said Tesla sold off sharply after its second-quarter (Q2) results disappointed on profitability, with price cuts and the wind-down of the Model S and Model X pressuring margins.But the firm also pointed to a recovery in the stock as Tesla publicly launched Cybercab in Austin and surpassed 1 million unsupervised robotaxi miles, up from 380,000 just six weeks earlier.Rocket Lab was another major drag, particularly in the space-focused portfolios. It contributed -1.39 points to ARKQ and -2.04 points to ARKX.The firm noted that Rocket Lab completed 21 flights in 2025 and had a backlog of more than 90 missions as of the second quarter.Ark's biggest winners included AI, AI-enabled biotech and other technology bets, while some of its highest-profile holdings, most notably Tesla and Rocket Lab, weighed on performance.<a href="https://stocktwits.com/symbol/ARKK">ARKK ETF</a> declined nearly 5% in Friday’s regular trading session and fell nearly 0.4% during the after-hours trade. Retail sentiment on Stocktwits around ARKK trended in the ‘bearish’ territory at the time of writing.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-denies-spacex-starlink-slowed-down-white-house-elon-musk/cZxkR3ARBtB">Trump Denies SpaceX’s Starlink Was Slowed Down Over Ukraine By Either White House Or Elon Musk: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cathie Wood, chief executive officer and chief investment officer, Ark Invest, gestures as she speaks during the Bitcoin 2022 Conference at Miami Beach Convention Center on April 7, 2022. (Photo by Marco Bello/Getty Images)

Cathie Wood-Led Ark Invest's Biggest Q3 Winners and Losers — PLTR, NVDA, TXG Led While TSLA, RKLB Dragged

ARK Fintech Innovation ETF

ARK Investment Management LLC - ARK Genomic Revolution ETF

ARK Innovation ETF

ARK Next Generation Internet ETF

ARK Space Exploration & Innovation ETF

Palantir Technologies Inc

Rocket Lab USA Inc

Tempus AI Inc

Twist Bioscience Corp

10x Genomics Inc - Ordinary Shares - Class A

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

Meta ($META) reports earnings after the close today. What do you expect?

Stocktwits

) reports earnings after the close today. What do you expect?

Current Price	$49.96
Prev Close	$48.65
Open	$48.62
Dividend Yield	N/A
50-Day Moving Average	$48.96
Beta	N/A
Avg. Volume	3.88M
PE Ratio	N/A

52-Week High	$58.83
52-Week Low	$24.60
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

ARKG Fundamentals